🇯🇵 Cellcept in Japan

PMDA authorised Cellcept on 25 June 2021

Marketing authorisation

PMDA — authorised 25 June 2021

  • Marketing authorisation holder: CHUGAI PHARMACEUTICAL Co., Ltd
  • Status: approved

Cellcept in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Cellcept approved in Japan?

Yes. PMDA authorised it on 25 June 2021.

Who is the marketing authorisation holder for Cellcept in Japan?

CHUGAI PHARMACEUTICAL Co., Ltd holds the Japanese marketing authorisation.